688073 Bide Pharmatech
- 32.27
- +0.07+0.22%
Bide Pharmatech News
Special Explanation on Financial Issues Relevant to the Inquiry Letter on 2023 Annual Report of BiDe Pharmaceutical by Zhonghui Certified Public Accountants
Haitong Securities Co., Ltd.'s verification opinion on the differential dividend of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement on holding the results briefing for the first quarter of 2023 and 2024
Independent Director Candidate Statements and Commitments
Independent Director Nominee Statements and Commitments
Nomination Committee's review opinions on independent director candidates
Haitong Securities Co., Ltd. report on the 2023 continuous supervision site inspection report of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Haitong Securities Co., Ltd.'s 2023 Continuous Supervision Annual Follow-up Report on Shanghai Bide Pharmaceutical Technology Co., Ltd.
Shanghai Bide Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (April 26, 2024)
2023 Audit Report
Special review instructions for non-operating capital occupation and other related capital transactions
Independent Director's Debriefing Report-Liu Zhichang
2023 Internal Control Audit Report
2023 Accounting Firm Performance Assessment Report
Independent Director's Debriefing Report-Meng Hong
Zhonghui Certified Public Accountants Audit Report on the Actual Storage and Use of Funds Raised by Bide Pharmaceuticals in 2023
Independent Director's Debriefing Report-Tao Yongping
Announcement of Resolutions of the 7th Meeting of the 2nd Board of Directors
Announcement of Resolutions of the Sixth Meeting of the Second Board of Supervisors
Special report on the storage and use of funds raised in 2023
Analysis
Price Target
No Data
